doi:US5834206 AStephan NeuenhoferReinhard KasmarkerUSUS5834206 * Dec 7, 1995 Nov 10, 1998 Behring Diagnostics Gmbh Immunoassays for haptens and hapten tracer-antibody complex which can be used therefor, and process for the preparation thereof...
A) major histocompatibility complex (MHC) molecules bound to antigens B) self-antigens C) immunogens D) haptens bound with a protein carrierBasophil: a) Antibodies b) Perforin c) Histamine d) CytokinesChoose the term that...
Which of these is not a role of the lymph nodes? (a) Produce lymphocytes (b) Filter lymph (c) Activate immunity in response to antigens (d) Produce lymph fluid and cerebrospinal fluid. Which type of lymphocyte is located on the surf...
Novel hapten-carrier conjugates are capable of inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in its native (S)-(鈭 ...
The following are claimed: (A) hapten tracer complex comprising: (a) a hapten which is linked, directly or via a spacer gp., to an indicator component and (b) an antibody which can bind specifically to the indicator component and (B) test kit for carrying out immunoassays for determn. ...
to establish a festphasenmatrix, the haptene covalently conjugated, binds the hapten in the phase to solid phase; material directly without binding of spacers by implementing the at least one covalently haptens containing functional group to a festphasenmaterial; d he two components had been ...
the nucleic acid probe includes a polynucleotide probe is presented for a marker of hapten and a fraction of affair. the probe includes a probe protein protein, a marker of hapten and a portion for binding. the marker for the hapten binding fraction) may include a marking sulfoph u00e9nyl...
An of the article concerning 2-year maintenance treatment in ileocecal crohn's disease with prednisolone or budesonide capsules is presented.doi:10.1111/j.1572-0241.2003.08498.xStockbruggerRWSchoonEBollaniSPerssonTHapten-WhiteCROSSREFAmerican Journal of Gastroenterology...
The present invention concerns novel conjugates, process for manufacturing them, and the use of such conjugates as antigens in immunological detection processes or in DNA diagnostic procedures.JOSEL HANS-PETERFINKE ANDREASHERRMANN RUPERTHOESS EVA
The invention relates to the use of a binding member which binds to Lewisy and Lewisb haptens in the treatment of tumours and leukaemia. The binding member may be an antibody which binds to Lewisy and Lewisb haptens and cancer cells and induces cells death.DURRANT Linda Gillian...